Literature DB >> 30593829

Functional interdependence of hematopoietic stem cells and their niche in oncogene promotion of myeloproliferative neoplasms: the 159th biomedical version of "it takes two to tango".

Huichun Zhan1, Kenneth Kaushansky2.   

Abstract

The role of stem cells in normal and neoplastic hematopoiesis is well established. However, neither normal nor neoplastic hematopoietic stem cells (HSCs) develop in isolation and accumulating evidence indicates that a critical developmental role is played by the perivascular "niche." The cellular, humoral, and cell surface contacts that provide the proper environment for HSC survival, proliferation, and differentiation are becoming increasingly better understood. A number of studies have established that endothelial cells (ECs), several types of perivascular stromal cells, and megakaryocytes (MKs) provide several cell surface and secreted molecules required for HSC development. Accumulating evidence also indicates that the normal stem cell niche is altered in patients with hematological neoplasms and that the "neoplastic niche" plays an important role in promoting malignant and suppressing normal blood cell development in such patients. To explore this concept in the myeloproliferative neoplasms (MPNs), we employed a murine model to determine the effects of Jak2V617F, an oncogene found in a majority of such patients, in marrow ECs and MKs and their effect on promoting neoplastic and suppressing normal hematopoiesis. We found that Jak2V617F has profound effects on both cell types, which together are critical for the growth advantage and radioresistance shown by Jak2V617F-bearing HSCs. Such findings should provide new approaches to the treatment of patients with MPNs.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30593829      PMCID: PMC6814245          DOI: 10.1016/j.exphem.2018.12.004

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  47 in total

1.  Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation.

Authors:  Vittorio Rosti; Laura Villani; Roberta Riboni; Valentina Poletto; Elisa Bonetti; Lorenzo Tozzi; Gaetano Bergamaschi; Paolo Catarsi; Elena Dallera; Francesca Novara; Margherita Massa; Rita Campanelli; Gabriela Fois; Benedetta Peruzzi; Marco Lucioni; Paola Guglielmelli; Alessandro Pancrazzi; Giacomo Fiandrino; Orsetta Zuffardi; Umberto Magrini; Marco Paulli; Alessandro M Vannucchi; Giovanni Barosi
Journal:  Blood       Date:  2012-11-05       Impact factor: 22.113

Review 2.  Normal and leukemic stem cell niches: insights and therapeutic opportunities.

Authors:  Koen Schepers; Timothy B Campbell; Emmanuelle Passegué
Journal:  Cell Stem Cell       Date:  2015-03-05       Impact factor: 24.633

3.  A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.

Authors:  Chloé James; Valérie Ugo; Jean-Pierre Le Couédic; Judith Staerk; François Delhommeau; Catherine Lacout; Loïc Garçon; Hana Raslova; Roland Berger; Annelise Bennaceur-Griscelli; Jean Luc Villeval; Stefan N Constantinescu; Nicole Casadevall; William Vainchenker
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

4.  Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo.

Authors:  Ralph Tiedt; Tibor Schomber; Hui Hao-Shen; Radek C Skoda
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

5.  JAK2V617F-mutant vascular niche contributes to JAK2V617F clonal expansion in myeloproliferative neoplasms.

Authors:  Chi Hua Sarah Lin; Kenneth Kaushansky; Huichun Zhan
Journal:  Blood Cells Mol Dis       Date:  2016-11-04       Impact factor: 3.039

6.  Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin.

Authors:  K Kaushansky; S Lok; R D Holly; V C Broudy; N Lin; M C Bailey; J W Forstrom; M M Buddle; P J Oort; F S Hagen
Journal:  Nature       Date:  1994-06-16       Impact factor: 49.962

7.  Lineage-Biased Hematopoietic Stem Cells Are Regulated by Distinct Niches.

Authors:  Sandra Pinho; Tony Marchand; Eva Yang; Qiaozhi Wei; Claus Nerlov; Paul S Frenette
Journal:  Dev Cell       Date:  2018-02-15       Impact factor: 12.270

8.  JAK2V617F Megakaryocytes Promote Hematopoietic Stem/Progenitor Cell Expansion in Mice Through Thrombopoietin/MPL Signaling.

Authors:  Yu Zhang; Chi Hua Sarah Lin; Kenneth Kaushansky; Huichun Zhan
Journal:  Stem Cells       Date:  2018-07-29       Impact factor: 6.277

9.  Thrombocytopenia in c-mpl-deficient mice.

Authors:  A L Gurney; K Carver-Moore; F J de Sauvage; M W Moore
Journal:  Science       Date:  1994-09-02       Impact factor: 47.728

10.  The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms.

Authors:  H Zhan; C H S Lin; Y Segal; K Kaushansky
Journal:  Leukemia       Date:  2017-07-24       Impact factor: 11.528

View more
  4 in total

1.  Shared and Tissue-Specific Expression Signatures between Bone Marrow from Primary Myelofibrosis and Essential Thrombocythemia.

Authors:  Genta Ishikawa; Naoto Fujiwara; Hadassa Hirschfield; Lilian Varricchio; Yujin Hoshida; Giovanni Barosi; Vittorio Rosti; Maria Padilla; Maria Mazzarini; Scott L Friedman; Ronald Hoffman; Anna Rita Migliaccio
Journal:  Exp Hematol       Date:  2019-11-01       Impact factor: 3.084

Review 2.  Amino Acid-Mediated Metabolism: A New Power to Influence Properties of Stem Cells.

Authors:  Jilan Liu; Xianyun Qin; Dongfeng Pan; Bin Zhang; Feng Jin
Journal:  Stem Cells Int       Date:  2019-12-05       Impact factor: 5.443

3.  Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm.

Authors:  Melissa Castiglione; Ya-Ping Jiang; Christopher Mazzeo; Sandy Lee; Juei-Suei Chen; Kenneth Kaushansky; Wei Yin; Richard Z Lin; Haoyi Zheng; Huichun Zhan
Journal:  J Thromb Haemost       Date:  2020-10-05       Impact factor: 16.036

Review 4.  The possible role of mutated endothelial cells in myeloproliferative neoplasms.

Authors:  Mirko Farina; Domenico Russo; Ronald Hoffman
Journal:  Haematologica       Date:  2021-11-01       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.